Here's How Teva Pharmaceuticals Pulled Off a 28.3% Gain in the First Half of 2018

Demand for generic drugs is on the rise, and investors are convinced the trend will keep this profitable company moving in the right direction. …read more

Source:: Yahoo Finance

      

Did you enjoy this article? Join our FREE Newsletter!
I agree to have my personal information transfered to MailChimp ( more information )
Join over 100,000 investors and business leaders worldwide. Get the latest actionable business and investing intelligence before the rest of the crowd.
We hate spam. Your email address will not be sold or shared with anyone else.